Rovi wins Spanish contract for flu vaccines

pharmafile | July 1, 2009 | News story | Manufacturing and Production, Research and Development Europe, Rovi, Spain 

Related Content

EC approves combination treatment for kidney cancer

The European Commission (EC) has approved Ipsen’s Cabometyx in combination with Opdivo as a first-line …

spravato

Janssen’s esketamine nasal spray gets Europe approval for new indication

The European Commission (EC) has authorised the expanded use of Janssen’s Spravato (esketamine nasal spray), co-administered …

xellia

Xellia Pharmaceuticals becomes member of Medicines for Europe

Xellia Pharmaceuticals, a manufacturer of specialty anti-infective treatments, has become a member of Medicines for …

Latest content